Galectin Therapeutics
GALT
#9252
Rank
$77.82 M
Marketcap
$1.24
Share price
-0.80%
Change (1 day)
-31.11%
Change (1 year)

Market capitalization of Galectin Therapeutics (GALT)

Market cap: $77.82 Million USD

As of January 2025 Galectin Therapeutics has a market cap of $77.82 Million USD. This makes Galectin Therapeutics the world's 9252th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galectin Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025$77.82 M7.83%
2024$72.17 M-29.7%
2023$0.10 B52.89%
2022$67.15 M-45.33%
2021$0.12 B-3.92%
2020$0.12 B-21.43%
2019$0.16 B15.17%
2018$0.14 B18.69%
2017$0.11 B277.16%
2016$31.56 M-33.24%
2015$47.27 M-38.85%
2014$77.3 M-47.97%
2013$0.14 B351.23%
2012$32.92 M-55.49%
2011$73.97 M28.62%
2010$57.51 M297.01%
2009$14.48 M235.73%
2008$4.31 M-84.73%
2007$28.25 M93.09%
2006$14.63 M-82.44%
2005$83.31 M22%
2004$68.28 M-28.2%
2003$95.11 M72.31%
2002$55.2 M

End of Day market cap according to different sources

On Jan 17th, 2025 the market cap of Galectin Therapeutics was reported to be:

$77.82 Million USD
by Nasdaq info icon info icon
$77.82 Million USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$4.11 B 5,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.65 B 2,029.69%๐Ÿ‡บ๐Ÿ‡ธ USA